Physician profile
Justin Winas
NPI 1679789010
$7,759.15
in general payments reported to CMS, 2019-2025
39 companies · $879 in 2025
The $879 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $872 · 2021: $646 · 2022: $819 · 2023: $882 · 2024: $2,306 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,728 · Travel and Lodging: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,727.99 |
| Travel and Lodging | $338.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,384.56 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Intracept Rf Probe |
| Abbott Laboratories | $860.23 | 2019-2025 | Octrode, Penta, Eterna |
| Collegium Pharmaceutical, INC. | $853.63 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $722.41 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $613.18 | 2019-2025 | Relistor |
| Vertos Medical, INC. | $529.33 | 2021-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $384.03 | 2023-2025 | Prospera, Biotronik |
| Scilex Pharmaceuticals INC. | $314.29 | 2019-2021 | |
| Medtronic, INC. | $286.08 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbvie INC. | $250.03 | 2023-2025 | Ubrelvy, Qulipta |
| Pfizer INC. | $146.83 | 2019-2025 | |
| Daiichi Sankyo INC. | $125.94 | 2019 | |
| Relievant Medsystems, INC. | $117.01 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $114.78 | 2024-2025 | |
| Averitas Pharma INC. | $110.66 | 2024-2025 | Qutenza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $96.24 | 2024-2025 | Evoke |
| Astrazeneca Pharmaceuticals LP | $86.56 | 2024-2025 | Wainua |
| Arbor Pharmaceuticals, INC. | $80.49 | 2019-2021 | |
| Forte Bio-Pharma LLC | $71.91 | 2019-2022 | |
| Vertiflex, INC. | $71.44 | 2019 | |
| Kaleo, INC. | $49.51 | 2019 | |
| Mml US, INC. | $49.50 | 2023-2025 | Reactiv8 |
| Biohaven Pharmaceutical Holding Company LTD. | $49.14 | 2022 | |
| Ibsa Pharma INC. | $47.89 | 2023-2024 | Tirosint, Licart, Licart |
| Medtronic USA, INC. | $41.38 | 2019 | |
| Electronic Waveform Lab, INC. | $34.11 | 2019-2024 | |
| Nalu Medical, INC. | $33.80 | 2024 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $28.89 | 2019-2021 | |
| Shionogi INC | $27.46 | 2019 | |
| Spinal Simplicity, LLC | $25.05 | 2025 | Ha Minuteman G3-R |
| Redhill Biopharma INC. | $20.49 | 2020 | |
| Lilly USA, LLC | $19.18 | 2023 | Emgality |
| Prescient Lab Services, LLC | $17.76 | 2025 | Avertd Amplification Mix, Avertd Intellipac Reagent Module, Avertd Biofilmchip Microarray Magazine |
| Foundation Fusion Solutions, LLC | $17.55 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.51 | 2019 | |
| Globus Medical, INC. | $16.74 | 2025 | Senza |
| Grt US Holding, INC. | $16.50 | 2021 | |
| Convatec INC. | $15.95 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Winas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.